- Report
- May 2025
- 150 Pages
Global
From €4325EUR$4,850USD£3,702GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1115EUR$1,250USD£954GBP
- Report
- May 2025
- 191 Pages
Global
From €3161EUR$3,545USD£2,706GBP
€3513EUR$3,939USD£3,007GBP
- Report
- May 2025
- 196 Pages
Global
From €3161EUR$3,545USD£2,706GBP
€3513EUR$3,939USD£3,007GBP
- Report
- May 2025
- 184 Pages
Global
From €3161EUR$3,545USD£2,706GBP
€3513EUR$3,939USD£3,007GBP
- Report
- May 2025
- 187 Pages
Global
From €3161EUR$3,545USD£2,706GBP
€3513EUR$3,939USD£3,007GBP
- Report
- April 2025
- 200 Pages
Global
From €4004EUR$4,490USD£3,427GBP
- Report
- April 2025
- 200 Pages
Global
From €4004EUR$4,490USD£3,427GBP
- Report
- April 2025
- 200 Pages
Global
From €4004EUR$4,490USD£3,427GBP
- Report
- June 2025
- 282 Pages
Global
From €5217EUR$5,850USD£4,466GBP
- Report
- June 2025
- 363 Pages
Global
From €5217EUR$5,850USD£4,466GBP
- Report
- May 2025
- 100 Pages
Global
From €2487EUR$2,789USD£2,129GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1115EUR$1,250USD£954GBP
- Report
- July 2024
- 100 Pages
Global
From €3344EUR$3,750USD£2,863GBP
- Report
- February 2025
- 181 Pages
Global
From €3411EUR$3,825USD£2,920GBP
€4013EUR$4,500USD£3,435GBP
- Report
- January 2025
- 180 Pages
Global
From €3411EUR$3,825USD£2,920GBP
€4013EUR$4,500USD£3,435GBP
- Report
- February 2025
- 120 Pages
Global
From €3893EUR$4,365USD£3,332GBP
€4325EUR$4,850USD£3,702GBP
- Report
- October 2022
- 119 Pages
Global
From €4013EUR$4,500USD£3,435GBP
- Report
- January 2024
- 200 Pages
Global
From €3701EUR$4,150USD£3,168GBP
- Report
- February 2023
- 198 Pages
Global
From €6688EUR$7,500USD£5,725GBP

The Orexin Receptor market is a subset of the Central Nervous System Drugs market. It is composed of drugs that target the Orexin Receptor, a protein found in the brain that is involved in the regulation of sleep and wakefulness. Orexin Receptor agonists are used to treat narcolepsy, a sleep disorder characterized by excessive daytime sleepiness. Orexin Receptor antagonists are used to treat insomnia, a sleep disorder characterized by difficulty falling asleep or staying asleep.
The Orexin Receptor market is a rapidly growing segment of the Central Nervous System Drugs market. It is expected to experience strong growth in the coming years due to the increasing prevalence of sleep disorders and the development of new drugs targeting the Orexin Receptor.
Some companies in the Orexin Receptor market include Merck, Pfizer, GlaxoSmithKline, Sanofi, and Takeda. Show Less Read more